Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine to reduce emergence agitation after sevoflurane anesthesia
IRCT20160430027677N14Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in Emergence agitation (EA), sponsored by Urmia University of Medical Sciences. Started Jan 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on IRCT20160430027677N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160430027677N14.